Organon (OGN) Change in Account Payables (2020 - 2026)

Organon (OGN) recorded quarterly Change in Account Payables of $32.0 million in Q1 2026, up 126.67% quarter-over-quarter from -$120.0 million in Q4 2025, and up 121.48% on a YoY basis from $14.4 million in Q1 2025.

Organon (OGN) Change in Account Payables (2020 - 2026) Analysis & Trends

Organon's Change in Account Payables history runs 7 years deep, the most recent figure standing at $32.0 million for Q1 2026.

  • In Q1 2026, Change in Account Payables rose 121.48% year-over-year to $32.0 million; the TTM figure through Mar 2026 stood at -$36.0 million (down 183.72% YoY), while the FY2025 annual figure was -$217.0 million, down 38.22% from the prior year.
  • Change in Account Payables was $32.0 million for Q1 2026 at Organon, up from -$120.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $293.0 million in Q2 2024 to a low of -$349.0 million in Q1 2024.
  • Historically, Change in Account Payables has averaged -$24.5 million across 5 years, with a median of $12.0 million in 2025.
  • The sharpest annual moves came in 2022 and 2023: Change in Account Payables plunged 7550.0% in 2022, then soared 168.6% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at $86.0 million in 2022, then soared by 168.6% to $231.0 million in 2023, then slumped by 74.89% to $58.0 million in 2024, then plunged by 306.9% to -$120.0 million in 2025, then soared by 126.67% to $32.0 million in 2026.
  • The last three Change in Account Payables figures came in at $32.0 million (Q1 2026), -$120.0 million (Q4 2025), and $12.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn -
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn -
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn -
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn -
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn -
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 571.00 Mn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn -67.00 Mn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn -
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn 409.00 Mn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 32.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 32.00 Mn
Mar 31, 2026 32.00 Mn
Dec 31, 2025 -120.00 Mn
Dec 31, 2025 -120.00 Mn
Sep 30, 2025 12.00 Mn
Sep 30, 2025 12.00 Mn
Jun 30, 2025 40.00 Mn
Jun 30, 2025 40.00 Mn
Mar 31, 2025 -149.00 Mn
Mar 31, 2025 -149.00 Mn
Dec 31, 2024 58.00 Mn
Dec 31, 2024 58.00 Mn
Sep 30, 2024 -159.00 Mn
Sep 30, 2024 -159.00 Mn
Jun 30, 2024 293.00 Mn
Jun 30, 2024 293.00 Mn
Mar 31, 2024 -349.00 Mn
Mar 31, 2024 -349.00 Mn
Dec 31, 2023 231.00 Mn
Dec 31, 2023 231.00 Mn